Cargando…
Short-course PET based simultaneous integrated boost for locally advanced cervical cancer
BACKGROUND: Patients with large, locally advanced cervical cancers (LACC) are challenging to treat. The purpose of this work is to use 18F-FDG PET as planning basis for a short-course simultaneous integrated boost (SIB) in external beam radiotherapy of LACC in order to increase tumour shrinkage and...
Autores principales: | Arnesen, Marius Røthe, Rekstad, Bernt Louni, Stokke, Caroline, Bruheim, Kjersti, Løndalen, Ayca Muftuler, Hellebust, Taran Paulsen, Malinen, Eirik |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4788887/ https://www.ncbi.nlm.nih.gov/pubmed/26968827 http://dx.doi.org/10.1186/s13014-016-0612-z |
Ejemplares similares
-
Target volume delineation of anal cancer based on magnetic resonance imaging or positron emission tomography
por: Rusten, Espen, et al.
Publicado: (2017) -
Positron emission tomography guided dose painting by numbers of lung cancer: Alanine dosimetry in an anthropomorphic phantom
por: Papoutsis, Iosif, et al.
Publicado: (2022) -
Assessment of pulmonary (18)F-FDG-PET uptake and cytokine profiles in non-small cell lung cancer patients treated with radiotherapy and erlotinib
por: Abravan, Azadeh, et al.
Publicado: (2017) -
FDG PET/CT and Dosimetric Studies of (177)Lu-Lilotomab Satetraxetan in a First-in-Human Trial for Relapsed Indolent non-Hodgkin Lymphoma—Are We Hitting the Target?
por: Løndalen, Ayca, et al.
Publicado: (2022) -
FDG PET/CT parameters and correlations with tumor-absorbed doses in a phase 1 trial of (177)Lu-lilotomab satetraxetan for treatment of relapsed non-Hodgkin lymphoma
por: Løndalen, Ayca, et al.
Publicado: (2020)